

VIVEbiotech participa en el proyecto europeo MAGIC
El consorcio MAGIC pretende
tener un impacto significativo en la vida de personas afectadas por distrofias musculares.

CRISPR-Cas:From biology to therapeutic
7–10 November 2023 | Seville, Spain SETGYC fellowships available • Scientific program now available on https://meetings.embo.org/event/...


Global Awards for Research in DMD-AWARD
Pfizer Global Medical Grants have opened a request for proposals that advance our understanding of Duchenne muscular dystrophy.